Detects SARS-CoV-2 nucleocapsid protein antigen
Rapid results in 15-20 minutes
Large manufacturing capacity and immediately available for distribution
Global sales and regulatory approval throughout Europe, Asia and South America
Selected by NIH for the Rapid Acceleration of Diagnostics program, for the US production of the GenBody COVID-19 Ag test.
Made in the USA (Q1 2021) and South Korea
The GenBody COVID-19 Ag test detects the Sars-CoV-2 variants.